Skip to Main Content

Paper Details

ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>.
Mol Cancer Ther
11
2021
ATF4, BBC3, DDIT3, DUSP8, IGFBP2, KLF9, LZTFL1, MKNK2, MTC, MTC cells, MTC xenograft, Medullary Thyroid Cancer, ONC201, RET, RET abnormalities, SESN2, VEGF, VEGFR2, VEGFR2 mRNA, VEGFR2 protein, cancer, mRNA, medullary thyroid carcinoma, patients, primary tumors, receptor tyrosine kinase, target genes, tumor, tyrosine, xenografts
Author NameAffiliation
Rozita Bagheri-YarmandThe University of Texas MD Anderson Cancer Center
Rohinton S TaraporeInc.
Joshua E AllenInc.
Michelle D WilliamsThe University of Texas MD Anderson Cancer Center
Robert F GagelThe University of Texas MD Anderson Cancer Center
  • 1 - 5

Datasets

Release 1.2